Marinomed Biotech AG | WebDisclosure

BRIEF

published on 09/17/2025 at 13:53, 9 months 29 days ago

Marinomed Biotech AG annonce une croissance significative au premier semestre 2025

Résultats Financiers Augmentation Des Revenus Croissance Du Résultat D'exploitation (EBIT) Croissance De La Biotechnologie Mesures De Capital
BRIEF

published on 09/17/2025 at 13:53, 9 months 29 days ago

Marinomed Biotech AG Reports Significant Growth in H1 2025

Financial Results Revenue Increase EBIT Growth Capital Measures Biotech Growth
PRESS RELEASE

published on 09/17/2025 at 13:48, 9 months 29 days ago

Marinomed Biotech AG announces results for the first half year of 2025
Marinomed Biotech AG reports strong financial results for the first half of 2025, with revenues of EUR 7.2 million and EBIT of EUR 21.0 million. The company secured financing through capital measures

Revenues Financial Results EBIT Marinomed Biotech AG Capital Measures
BRIEF

published on 09/16/2025 at 15:27, 10 months ago

Marinomed Biotech AG annonce une augmentation de capital

Investissement Augmentation De Capital Marinomed Biotech AG Émission D'actions Industrie Biotechnologique
BRIEF

published on 09/16/2025 at 15:27, 10 months ago

Marinomed Biotech AG Announces Capital Increase

Investment Biotech Industry Capital Increase Share Issuance Marinomed Biotech AG
PRESS RELEASE

published on 09/16/2025 at 15:22, 10 months ago

EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share
Marinomed Biotech AG resolves capital increase by issuing 61.607 bearer shares at EUR 17,50 per share, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights Bearer Shares EUR 17,50
BRIEF

published on 09/01/2025 at 12:01, 10 months 15 days ago

Marinomed Biotech AG Secures EUR 2.5 Million Convertible Bond Agreement

Financing Investment Strategy Shareholder Rights Convertible Bond Marinomed Biotech
BRIEF

published on 09/01/2025 at 12:01, 10 months 15 days ago

Marinomed Biotech AG obtient un accord d'émission d'obligations convertibles de 2,5 millions d'euros

Financement Stratégie D'investissement Droits Des Actionnaires Marinomed Biotech Obligation Convertible
PRESS RELEASE

published on 09/01/2025 at 11:56, 10 months 15 days ago

EQS-Adhoc: Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond
Marinomed Biotech AG announces agreement on key terms for a secured EUR 2.5mn convertible bond issue, including interest rate and conversion price

Marinomed Biotech AG Convertible Bond Secured EUR 2.5mn Key Terms
BRIEF

published on 06/30/2025 at 12:56, 1 year ago

Marinomed Biotech AG : Perspectives positives dans un contexte de redressement stratégique

Restructuration Financière Marinomed Biotech AG Innovation Biotechnologique Plateforme Marinosolv® Développement Budesolv

Published on 07/17/2026 at 01:00, 2 hours 49 minutes ago

RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 3 hours 49 minutes ago

LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
Published on 07/16/2026 at 16:21, 11 hours 28 minutes ago

First Canadian Graphite Completes Phase I Exploration on Zone 13 Discovery and Expands Lands Package
Published on 07/16/2026 at 15:30, 12 hours 19 minutes ago

Caldwell Announces Leadership Appointments for Industrial Practice and Caldwell Analytics
Published on 07/16/2026 at 15:30, 12 hours 19 minutes ago

Resilient Energy Inc. Advances Commercial Rollout; Operations Enter Final Stage Ahead of Revenue Generation

View all ACCESSWIRE

Published on 07/17/2026 at 02:10, 1 hour 38 minutes ago

VARON Highlights Summer Wellness with Portable Oxygen Solutions for Active Lifestyles
Published on 07/16/2026 at 23:10, 4 hours 39 minutes ago

EQS-Adhoc: Ad-hoc: Marinomed Biotech AG plans to apply for court restructuring proceedings without self-administration
Published on 07/16/2026 at 21:16, 6 hours 33 minutes ago

Hertz Energy Advances Its Lake George Antimony-Tungsten Project and Summarizes Lithium Project
Published on 07/16/2026 at 20:59, 6 hours 50 minutes ago

EQS-Adhoc: SMA publishes preliminary results for the second quarter of 2026 and raises full-year 2026 guidance
Published on 07/16/2026 at 20:39, 7 hours 9 minutes ago

AUTODOC successfully optimises capital structure

View all EQS

Published on 07/16/2026 at 20:27, 7 hours 22 minutes ago

BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE
Published on 07/16/2026 at 18:08, 9 hours 40 minutes ago

Aéroports de Paris S.A - June and half-year 2026 traffic figures
Published on 07/16/2026 at 18:08, 9 hours 40 minutes ago

Aéroports de Paris S.A - Trafic du mois de juin et du 1er semestre 2026
Published on 07/16/2026 at 18:00, 9 hours 49 minutes ago

i2S Chiffre d'affaires S1 2026
Published on 07/16/2026 at 17:45, 10 hours 4 minutes ago

H1 2026 revenue: €6.1m (+14%)

View all LES ECHOS COMFI WIRE

News